330 related articles for article (PubMed ID: 24913055)
1. Immune thrombocytopenia in chronic myelomonocytic leukemia.
Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Jachiet V; Moulis G; Hadjadj J; Seguier J; Laribi K; Schleinitz N; Vey N; Sacre K; Godeau B; Beyne-Rauzy O; Bouvet R; Broner J; Brun N; Comont T; Gaudin C; Lambotte O; Le Clech L; Peterlin P; Roy-Peaud F; Salvado C; Versini M; Isnard F; Kahn JE; Gobert D; Adès L; Fenaux P; Fain O; Mekinian A
Haematologica; 2021 May; 106(5):1414-1422. PubMed ID: 33626866
[TBL] [Abstract][Full Text] [Related]
3. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
Gao Y; Gong M; Zhang C; Kong X; Ma Y
Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
[TBL] [Abstract][Full Text] [Related]
4. Not all cases of idiopathic thrombocytopenic purpura [correction of pupura] are what they might first seem.
Mainwaring CJ; Shutt J; James CM
Clin Lab Haematol; 2002 Aug; 24(4):261-2. PubMed ID: 12181032
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Elbæk MV; Sørensen AL; Hasselbalch HC
Leuk Lymphoma; 2016 Aug; 57(8):1793-9. PubMed ID: 26879691
[TBL] [Abstract][Full Text] [Related]
6. [Chronic myelomonocytic leukemia].
Kalnberza GK; Rotsena AIa; Bondare DK; Teĭlane IIa; Grant KhIa
Ter Arkh; 1988; 60(11):120-3. PubMed ID: 3238562
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
Wijermans PW; Rüter B; Baer MR; Slack JL; Saba HI; Lübbert M
Leuk Res; 2008 Apr; 32(4):587-91. PubMed ID: 17881052
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
9. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?
Gunduz E; Kivanc BK; Arik D; Isiksoy S; Bal C; Akay OM
Eur J Haematol; 2014 Aug; 93(2):157-60. PubMed ID: 24660825
[TBL] [Abstract][Full Text] [Related]
11. Unusual skin lesions in chronic myelomonocytic leukemia.
McCollum A; Bigelow CL; Elkins SL; Hardy CL; Files JC
South Med J; 2003 Jul; 96(7):681-4. PubMed ID: 12940320
[TBL] [Abstract][Full Text] [Related]
12. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
13. [Chronic myelomonocytic leukemia developed 9 years after the diagnosis of idiopathic thrombocytopenic purpura in a child].
Fukuda M; Horibe K; Miyajima Y; Matsumoto K; Kozaki T; Komiyama A
Rinsho Ketsueki; 1994 Jun; 35(6):609-15. PubMed ID: 8078197
[TBL] [Abstract][Full Text] [Related]
14. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
Alfonso A; Montalban-Bravo G; Takahashi K; Jabbour EJ; Kadia T; Ravandi F; Cortes J; Estrov Z; Borthakur G; Pemmaraju N; Konopleva M; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G
Am J Hematol; 2017 Jul; 92(7):599-606. PubMed ID: 28370097
[TBL] [Abstract][Full Text] [Related]
15. Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia.
Aribi A; Borthakur G; Ravandi F; Shan J; Davisson J; Cortes J; Kantarjian H
Cancer; 2007 Feb; 109(4):713-7. PubMed ID: 17219444
[TBL] [Abstract][Full Text] [Related]
16. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
Singh ZN; Post GR; Kiwan E; Maddox AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelomonocytic leukemia presenting as relapsing thrombotic thrombocytopenic purpura.
Cai Y; Teng R; Lin Z; Zhang Y; Liu H
Aging Clin Exp Res; 2013 Jun; 25(3):349-50. PubMed ID: 23740594
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of chronic myelomonocytic leukemia.
Catalano L; Improta S; de Laurentiis M; Molica S; Majolino I; Musto P; Fragasso A; De Placido S; Rotoli B
Haematologica; 1996; 81(4):324-9. PubMed ID: 8870376
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.
Grignano E; Mekinian A; Braun T; Liozon E; Hamidou M; Decaux O; Puéchal X; Kahn JE; Schoindre Y; Rossignol J; Lortholary O; Lioger B; Hermine O; Park S; Ades L; Montestruc F; Ricard L; Gardin C; Fenaux P; Fain O;
Leuk Res; 2016 Aug; 47():136-41. PubMed ID: 27337291
[TBL] [Abstract][Full Text] [Related]
20. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
